Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Blood Billing Rules Lead To Inadequate Reimbursement – Lewin Report

This article was originally published in The Gray Sheet

Executive Summary

Updated guidelines on properly billing CMS for blood products and services will soon be available to hospitals from the American Association of Blood Banks, the industry group announced Oct. 15

You may also be interested in...



Blood Banks, AdvaMed Collaborate To Improve Blood Product Payments

Various health industry organizations plan to compile data on the actual costs of blood in order to improve product reimbursement

Blood Banks, AdvaMed Collaborate To Improve Blood Product Payments

Various health industry organizations plan to compile data on the actual costs of blood in order to improve product reimbursement

Industry Perceptions Meet FDA Reality In AdvaMed/Lewin Survey Of 81 Firms

Respondents to 1AdvaMed's first "State of the Medical Technology Industry" survey are holding that "elapsed development times" associated with PMA devices are on the rise, despite FDA data showing shortened or static review times

Related Content

UsernamePublicRestriction

Register

LL1134786

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel